Topical dosage form of valdecoxib: Preparation and pharmacological evaluation

Acta Pharmaceutica

Volumn 57, Issue 2, 2007, Pages 199-209

  Kesavanarayanan, K S ^a   Nappinnai, Mohanavelu ^a   Ilavarasan, Raju ^a  

^a C L BAID METHA COLLEGE OF PHARMACY   (India)

Author keywords

In vitro; In vivo evaluation; Topical gel; Valdecoxib

Indexed keywords

CARBOMER; CARBOPOL 940; CETOSTEARYLIC ALCOHOL; CHLOROCRESOL; DRUG VEHICLE; EMULSIFYING AGENT; LANOLIN; LIQUID PARAFFIN; PLACEBO; PROPYLENE GLYCOL; ROFECOXIB; VALDECOXIB;

ADJUVANT ARTHRITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLEEDING TIME; BLOOD CLOTTING TIME; CONTROLLED STUDY; CREAM; DRUG DIFFUSION; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; GEL; GRANULATION TISSUE; HYPERALGESIA; IN VITRO STUDY; MALE; NONHUMAN; OINTMENT; PAW EDEMA; RAT; SKIN IRRITATION;

EID: 34248575890     PISSN: 13300075     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10007-007-0016-6     Document Type: Article

References (20)

1. V. V. Dhavse and D. Amin, Formulation and evaluation of topical bases of ketoprofen, Eastern Pharm. 40 (1997) 133-135.
2. www.fda.gov/cder/drug; accessed on 20 November 2006.
3. th ed., Lea Febiger, Philadelphia 1980, p. 1525.
4. J. Sawynok, Topical and peripherally acting analgesics, Pharmacol. Rev. 55 (2003) 1-20.
5. rd ed., Varghese Pub. House, Bombay 1987, pp. 534-563.
6. V. Rajani and P. R. P. Verma, Diffusion studies of Ibuprofen from ointment base, Indian J. Pharm. Sci. 57 (1995) 1-6.
7. K. P. R. Chowdary and R. A. S. Naidu, Transdermal diffusion of diclofenac sodium through cellulose acetate membrane and rat abdominal skin, Eastern Pharm. 36 (1993) 137-140.
8. A. N. Armstrong, T. G. Marim, K. C. James and P. Kearney, The influence of viscosity on the migration of chloramphenicol and 4-hydroxyl benzoic acid through glycerogelatin gels, J. Pharm. Pharmacol. 39 (1987) 583-586.
9. R. Ilango, S. Kavimani, K. Senthil Kumar, K. R. Deepa and B. Jaykar, Formulation and evaluation of transdermal preparation of nimesulide gel, Eastern Pharm. 41 (1998) 123-125.
10. Advance in Modern Toxicology (Eds. F. N. Marzulli and H. I. Maibach), Vol. 4, Hemisphere Publishing Corporation, London 1997, pp. 193-210.
11. Toxicology Principles and Practice (Ed. F. Sperling), Vol 4, Wiley Interscience Publication, New York 1984, pp. 168-177.
12. K. Kyuki, T. Shibuya, K. Tsurumi and H. Fujimura, Anti inflammatory effect of diclofenac sodium (cream) in topical application, Japan J. Pharmacol. 33 (1983) 121-132.
13. R. K. Goel, A. Singh, M. P. Mahajan and S. K. Kulkarni, Evaluation of anti inflammatory and anti hyperalgesic activity of some novel monocyclic β-lactam compounds in rats, Indian J. Pharm. Sci. 66 (2004) 87-91.
14. N. Narayanan, P. Thirugnanasambantham, S. Viswanathan, V. Vijayasekaran and E. Sukumar, Antinociceptive, antiinflammatory and antipyretic effects of ethanol extract of Clerodendron serratum roots in experimental animals, J. Ethnopharmacol. 65 (1999) 237-241; DOI: 10.1016/S0378-8741(98) 00176-7.
15. W. J. Herbert, The mode of action of mineral oil emulsion adjuvants on antibody production in mice, J. Immunol. 14 (1968) 301-318.
16. M. Fronza, M. Wrasse, L. Brun, M. S. Sangoi and S. Dalmora, Evaluation of the changes on hemostatic parameters induced by valdecoxib in male Wistar rats, Rev. Bras. Hematol. Hemoter. 28 (2006) 28-32.
17. A. G. Manzano, J. G. Llavan, C. Lemini and C. R. Poo, Standardization of rat blood clotting tests with reagents used for humans, Proc. West. Pharamcol. Soc. 44 (2001) 153-155.
18. J. J. Tally, D. L. Brown and J. S. Carter, 4-[5-Methyl-3-phenyl- lisoxazol-4-yl]-benzenesulfonamide, valdecoxib: a potent and selective inhibitor of COX-2, J. Med. Chem. 43 (2000) 775-777; DOI: 10.1021/jm990577v.
19. J. Fricke, J. Varkalis, S. Zwillich, K. Adler, E. Forester, D. P. Recker and M. Verburg, Valdecoxib is more efficacious than rofecoxib in relieving pain associated with oral surgery, Am. J. The. 9 (2002) 89-97.
20. K. S. Christensen and G. D. Cawkwell, Acute post surgical pain: results of randomized controlled trial, J. Pain Symptom. Manag. 27 (2004) 460-470.